Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

December 2026 407

  1. Study completion Effects of SGLT2 Inhibitors in Pre-heart Failure Populations With Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06055452

  2. Primary completion Effects of SGLT2 Inhibitors in Pre-heart Failure Populations With Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06055452

  3. Primary completion Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06108414

  4. Study completion Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06148285

  5. Primary completion Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06148285

  6. Study completion SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06155604

  7. Primary completion SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06155604

  8. Study completion Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06164808

  9. Primary completion Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06164808

  10. Primary completion VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06249165

  11. Study completion Left Roof Linear, Mitral Isthmus Linear and Left Anterior Septal Linear Ablation for Non-paroxysmal AF: PROMISED Trial. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06249347

  12. Primary completion Left Roof Linear, Mitral Isthmus Linear and Left Anterior Septal Linear Ablation for Non-paroxysmal AF: PROMISED Trial. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06249347

  13. Study completion Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06264427

  14. Study completion Head Down Tilt 15° to Increase Collateral Flow in Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06297863

  15. Primary completion CardioPROTECTion with Dapagliflozin in Breast Cancer Patients Treated with AnthrAcycline - PROTECTAA TRIAL Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06304857

  16. Study completion Butylphthalide's Safety and Efficacy for Improving Neurological Function Prognosis in Patients With Cardiac Arrest (BNCA Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06353334

  17. Primary completion Butylphthalide's Safety and Efficacy for Improving Neurological Function Prognosis in Patients With Cardiac Arrest (BNCA Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06353334

  18. Primary completion Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06399835

  19. Primary completion Clopidogrel Versus Cilostazol on Vessels Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06402747

  20. Study completion The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06416644

  21. Primary completion The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06416644

  22. Study completion Evaluation of Efficacy and Safety of Combination Therapy of Henagliflozin Proline, Retagliptin and Metformin in New Diagnosed Type 2 Diabetes Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06417489

  23. Study completion Reducing Salt and Sugar in Campus Foods: A Malaysian Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06473038

  24. Primary completion Reducing Salt and Sugar in Campus Foods: A Malaysian Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06473038

  25. Primary completion Priming Theta Burst Stimulation for Stroke: A Study of Intensity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06509789

  26. Primary completion Using Remote Monitoring to Address Health Disparities in Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06517576

  27. Study completion Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06520904

  28. Study completion The Impact of Real Time Ventilation Feedback on Ventilation Rate and Tidal Volume During Cardiac Arrest. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06528704

  29. Primary completion The Impact of Real Time Ventilation Feedback on Ventilation Rate and Tidal Volume During Cardiac Arrest. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06528704

  30. Study completion Endocardial Mapping With the CoreMap EP Mapping System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06529978

  31. Primary completion Endocardial Mapping With the CoreMap EP Mapping System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06529978

  32. Study completion EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06531824

  33. Primary completion EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06531824

  34. Study completion A Trail of Sperstent® Used for Residual Lesions of Femoropopliteal Arteries Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06539689

  35. Study completion Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06578234

  36. Primary completion Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06578234

  37. Study completion Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06643819

  38. Study completion To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06647550

  39. Study completion Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06668389

  40. Primary completion Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06668389

  41. Study completion Efficacy and Safety of Jia Shen Tablets in Chronic Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06669169

  42. Primary completion Efficacy and Safety of Jia Shen Tablets in Chronic Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06669169

  43. Study completion OBPM_COYOTE2024 Physiological Data Recording With the Calibration-free Optical Aktiia G2C Device at Fingertip and Wrist, Alongside the Aktiia Oscillometric Cuff Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06698536

  44. Primary completion OBPM_COYOTE2024 Physiological Data Recording With the Calibration-free Optical Aktiia G2C Device at Fingertip and Wrist, Alongside the Aktiia Oscillometric Cuff Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06698536

  45. Study completion Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06701825

  46. Study completion Impact of Catheter Stability on the Outcomes With Very High Power Short Duration Ablation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06721221

  47. Primary completion Impact of Catheter Stability on the Outcomes With Very High Power Short Duration Ablation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06721221

  48. Study completion Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06736899

  49. Primary completion Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06736899

  50. Primary completion Intravenous Thrombolysis and NOAC Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06749834

  51. Study completion Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06762223

  52. Primary completion Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06762223

  53. Primary completion TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06802081

  54. Study completion Motor-Cognitive Interactive Upper Limb Robot Rehabilitation for Post-Stroke Motor Dysfunction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06876597

  55. Primary completion Motor-Cognitive Interactive Upper Limb Robot Rehabilitation for Post-Stroke Motor Dysfunction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06876597

  56. Study completion Robot-Assisted Tai Chi for Upper Limb Rehabilitation in Stroke Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06897631

  57. Primary completion Robot-Assisted Tai Chi for Upper Limb Rehabilitation in Stroke Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06897631

  58. Study completion SONICURE(SONICracker for the Treatment of UndeRExpansion) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06924736

  59. Study completion Metformin Hydrochloride Sustained-release Tablets (Ⅲ) in Patients With Type 2 Diabetes Mellitus Complicated With Coronary Heart Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06932874

  60. Primary completion Metformin Hydrochloride Sustained-release Tablets (Ⅲ) in Patients With Type 2 Diabetes Mellitus Complicated With Coronary Heart Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06932874

  61. Study completion Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06946732

  62. Study completion Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06959784

  63. Primary completion Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06959784

  64. Study completion Gator SCALES-WHF: SubCutaneous Administration of Lasix to Eliminate Symptoms of Worsening Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06979726

  65. Primary completion Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06989723

  66. Study completion The Role of intraABDOminal Pressure and Point Of Care UltraSound to Guide Decongestive Therapy in Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07008365

  67. Study completion BM Shockwave Devices Clinical Study in Coronary Calcified Lesions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07010094

  68. Study completion Impact of Eszopiclone on Blood Pressure in Patients With Insomnia and Hypertension (PRYSMA-HTN) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07018557

  69. Study completion Nefecon and Ambrisentan in IgA Nephropathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07030894

  70. Primary completion Nefecon and Ambrisentan in IgA Nephropathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07030894

  71. Primary completion Trial of Mobile External Defibrillator for Out-of-hospital Cardiac Arrest in Singapore. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07042061

  72. Primary completion Monitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07067658

  73. Primary completion Traditional Chinese Medicine Intervention for Ischemic Cardiovascular Disease Comorbid With Diabetes Mellitus: An Efficacy Comparative Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07088523

  74. Study completion A Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07091994

  75. Primary completion A Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07091994

  76. Primary completion Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07121088

  77. Primary completion Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07122167

  78. Study completion Connected Care for Type 2 Diabetes Self-Management Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07149610

  79. Study completion ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07187713

  80. Study completion Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07225101

  81. Primary completion Comparison of the Amplatzer Amulet Versus LAmbre Device for Left Atrial Appendage Closure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07260474

  82. Study completion Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07290751

  83. Primary completion Oral Hygiene and Prophylactic Antibiotics to Prevent Intracerebral Hemorrhage Associated Pneumonia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07311343

  84. Primary completion Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07336329

  85. Study completion Study to Assess the Efficacy and Safety of QHRD106 Injection in Acute Ischemic Stroke. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07396337

  86. Study completion Aroxxen® Inhalation for Cardioprotection After Elective PCI With Stent Implantation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07397351

  87. Primary completion CART BP Pro-Guided Blood Pressure Management for Uncontrolled Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07465549

  88. Study completion OBPM_PANDA2026: Evaluation of the Performance and Safety of the Aktiia Periodic Optical Blood Pressure Monitoring Device Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07507903

  89. Primary completion OBPM_PANDA2026: Evaluation of the Performance and Safety of the Aktiia Periodic Optical Blood Pressure Monitoring Device Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07507903

  90. Study completion Digital Application for Stroke Health Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07511868

  91. Primary completion Digital Application for Stroke Health Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07511868

  92. Study completion Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07536802

  93. Primary completion Auricular Acupuncture Therapy Administered by Village Doctors Improves Sleep Quality in Elderly Patients With Comorbid Diabetes Mellitus and Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07554235

  94. Primary completion Pre-discharge Influenza Vaccination in Patients Hospitalized for Acute Cardiac Conditions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07617376

  95. Primary completion Effects of CTAR and a Swallowing Pressure Ball in Older Stroke Adults Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07620210

  96. Study completion Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System During TAVR: DUET Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07648693

  97. Primary completion A Randomized Trial of Carotid Artery Stenting With Balloon Guide Catheter Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07678164

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Primary completion CZECH-ICIT (CZECH Inflammatory Cardiomyopathy Immunosuppression Trial) Registry record

    Expected 2015-09; that period ended on 2015-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01877746

  2. Study completion Phase II Randomized Placebo-controlled Study With Vitamin K2 in Asymptomatic Calcified Carotid Stenosis Registry record

    Expected 2015-09; that period ended on 2015-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01923012

  3. Primary completion Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events Registry record

    Expected 2015-09; that period ended on 2015-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01923818

  4. Study completion Pharmacodynamic Comparison of Rosuvastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With New P2Y12 Inhibitors (Trial gRANADa) Registry record

    Expected 2015-09; that period ended on 2015-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02030054

  5. Study completion Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy Registry record

    Expected 2015-09; that period ended on 2015-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02129985

  6. Primary completion Effect of Paired Testing to Poorly Controlled Chinese Diabetes on Glycemic Control and Self Care Registry record

    Expected 2015-09; that period ended on 2015-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02225691

  7. Study completion Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Early Morning Blood Pressure and Central Arterial Pressure Registry record

    Expected 2015-09; that period ended on 2015-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02357615

  8. Study completion Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol Registry record

    Expected 2015-09; that period ended on 2015-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02403349

  9. Study completion The Effects of Ezetimibe on Coronary Plaque Volume in Patients With Acute Coronary Syndrome Registry record

    Expected 2015-10; that period ended on 2015-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01068093

  10. Primary completion The Effects of Ezetimibe on Coronary Plaque Volume in Patients With Acute Coronary Syndrome Registry record

    Expected 2015-10; that period ended on 2015-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01068093

  11. Study completion Optimizing Infarct Size by Transforming Emergent Stenting Into an Elective Procedure Study Registry record

    Expected 2015-10; that period ended on 2015-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01462188

  12. Study completion Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus Registry record

    Expected 2015-10; that period ended on 2015-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01954147

  13. Primary completion Paclitaxel-eluting Balloon Angioplasty With Provisional Use of Nitinol Stent Versus Systematic Implantation of Paclitaxel-eluting Stent for the Treatment of Femoropopliteal de Novo Lesions Registry record

    Expected 2015-10; that period ended on 2015-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01969630

  14. Primary completion Comparison of Titanium-Nitride-Oxide Coated Bio-Active-Stent (Optimax™) to the Drug (Everolimus) -Eluting Stent (Synergy™) in Acute Coronary Syndrome Registry record

    Expected 2015-10; that period ended on 2015-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02049229

  15. Primary completion Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients Registry record

    Expected 2015-10; that period ended on 2015-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02254824

  16. Study completion Efficacy and Safety Study of Guanxin Shutong Capsule to Treat Chronic Stable Angina Registry record

    Expected 2015-10; that period ended on 2015-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02280850

  17. Primary completion Anti-inflammatory Effects of Rivaroxaban Versus Dabigatran Registry record

    Expected 2015-10; that period ended on 2015-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02331602

  18. Primary completion Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential Hypertension Registry record

    Expected 2015-10; that period ended on 2015-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02407210

  19. Study completion Surgical Treatment of Ischemic Mitral Regurgitation Registry record

    Expected 2015-11; that period ended on 2015-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01368575

  20. Primary completion The Mobile Diabetes Mgmt. Study With Type 2 Diabetes Registry record

    Expected 2015-11; that period ended on 2015-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02451631

  21. Study completion Anticoagulation in Stent Intervention Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01141153

  22. Primary completion Anticoagulation in Stent Intervention Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01141153

  23. Primary completion Comparative Study of GangTrainer GT1, Lokomat and Conventional Physiotherapy Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01146587

  24. Study completion Comparison of Vascular Remodeling Between Different Antianginal Medication Evaluated by Noninvasive ECG-gated Fundus Photographic Evaluation Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01162902

  25. Study completion Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01175486

  26. Study completion The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01270191

  27. Study completion The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01278498

  28. Study completion Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN) Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01305148

  29. Primary completion Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN) Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01305148

  30. Study completion Catheter Ablation Versus Antiarrythmic Drugs for Atrial Fibrillation in China Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01341353

  31. Study completion Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01433627

  32. Study completion Customized Choice of Oral P2Y12 Receptor Blocker Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01477775

  33. Primary completion Effects of DES Platforms on Markers of Endothelial Damage and Inflammation Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01489202

  34. Primary completion Ranolazine Loading to Prevent PCI-induced Myocardial Injury Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01491061

  35. Primary completion N-GAL Allows Intensive Treatment of Contrast Induced Nephropathy Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01491243

  36. Primary completion PharmacOdynamic compaRison of piTavastatin Versus atOrvastatin on Platelet Reactivity Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01648829

  37. Primary completion Nutraceuticals to Improve Lipid Profile in European Countries Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01649986

  38. Primary completion Short-term Endothelin A Receptor Blockade in Patients With On-pump CABG Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01658410

  39. Study completion Study Examining the PROMUS Element Everolimus-eluting Stent in Multi-center Coronary Intervention of Complex Arterial Lesion Subsets Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01670318

  40. Primary completion Single Long vs Two Short Overlapping Bioabsorbable Polymer DES Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01718106

  41. Study completion Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01790308

  42. Primary completion Cholesterol-lowering Effects of nutraceuticaLs Versus Ezetimibe in Statin-intolerant Patients Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01807078

  43. Primary completion Graft Patency After FFR-guided Versus Angio-guided CABG (GRAFFITI) Trial Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01810224

  44. Primary completion Efficacy and Safety Study of Ticagrelor Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01812330

  45. Study completion Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01862978

  46. Primary completion Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01869309

  47. Study completion A Trial to Evaluate Efficacy of Heart-protecting Musk Pill Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01897805

  48. Primary completion Comparative Phase IV Study: Efficacy And Safety of TiTAN2 Versus COBALT-CHROME Stents- EVIDENCEII Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01918150

  49. Primary completion Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01924325

  50. Study completion Bedside Sleep Medicine Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01924507

  51. Study completion PaneLux PTCA : Proposing an Alternative Treatment to patiEnts for Whom DES Implantation is Not Indicated, Thanks to Pantera LUX Drug Eluting Balloon Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01930903

  52. Primary completion PaneLux PTCA : Proposing an Alternative Treatment to patiEnts for Whom DES Implantation is Not Indicated, Thanks to Pantera LUX Drug Eluting Balloon Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01930903

  53. Primary completion Comparison of the Quality of CPR by Lay Rescuers With and Without Feedback Devices Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02000505

  54. Study completion Low-dose Statins and Nutraceuticals in High-intensity Statin-intolerant Patients Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02001883

  55. Study completion Pulmonary Vein Isolation Versus Botulinum Toxin Injection Plus Pulmonary Vein Isolation in Patients With Atrial Fibrillation Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02002923

  56. Primary completion Optimizing Treatment Programs for Chronic Kidney Disease-mineral and Bone Disorder and Malnutrition Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02005302

  57. Primary completion Endomyocardial Botulinum Toxin Injection in Patients With Persistent Atrial Fibrillation Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02008448

  58. Primary completion Renal Denervation in Heart Failure Patients With Preserved Ejection Fraction (RESPECT-HF) Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02041130

  59. Study completion A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02059616

  60. Primary completion LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02077257

  61. Study completion A Clinical Trial of Danhong Injection in Treating Acute Ischemic Stroke Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02152280

  62. Primary completion A Clinical Trial of Danhong Injection in Treating Acute Ischemic Stroke Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02152280

  63. Primary completion the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI After the PTCA Surgery. Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02158559

  64. Primary completion Surgical Ablation of Long-standing Persistent AF During CABG Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02246790

  65. Primary completion Drug Eluting Balloon in peripherAl inTErvention for Below-The-Knee Arteries With Freeway and Lutonix Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02279784

  66. Study completion Effectiveness of a Combined Strategy to Improve Therapeutic Compliance and Degree of Control Among Patients With Hypercholesterolaemia Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02314663

  67. Primary completion Effectiveness of a Combined Strategy to Improve Therapeutic Compliance and Degree of Control Among Patients With Hypercholesterolaemia Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02314663

  68. Study completion Anti-inflammatory Effects of Rivaroxaban Versus Dabigatran Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02331602

  69. Primary completion Nitrates In Combination With Hydralazine in cardiorEnal Syndrome (NICHE) Study Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02343393

  70. Study completion A Study of tDCS for Swallowing Difficulties in Stroke Patients Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02422225

  71. Primary completion A Study of tDCS for Swallowing Difficulties in Stroke Patients Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02422225

  72. Primary completion Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02426294

  73. Primary completion The Pacing vs No Pacing Study - PNP Study Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02498639

  74. Study completion Health Education Using Text Messaging Prevents Hypertension in High Risk People Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02551926

  75. Primary completion Health Education Using Text Messaging Prevents Hypertension in High Risk People Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02551926

  76. Primary completion HFS-guided Renal Ablation for Improving Outcome of Renal Denervation Procedure Registry record

    Expected 2015-12; that period ended on 2015-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02608632

  77. Primary completion Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy Registry record

    Expected 2016-01; that period ended on 2016-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01823185

  78. Study completion Endomyocardial Botulinum Toxin Injection in Patients With Persistent Atrial Fibrillation Registry record

    Expected 2016-01; that period ended on 2016-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02008448

  79. Primary completion Treatment of Hypertension in Tibetan Adult Population Registry record

    Expected 2016-01; that period ended on 2016-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02217852

  80. Study completion Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention Registry record

    Expected 2016-01; that period ended on 2016-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02334254

  81. Primary completion Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention Registry record

    Expected 2016-01; that period ended on 2016-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02334254

  82. Study completion The Pacing vs No Pacing Study - PNP Study Registry record

    Expected 2016-01; that period ended on 2016-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02498639

  83. Primary completion Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD Registry record

    Expected 2016-01; that period ended on 2016-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02551172

  84. Study completion Comparative Study of GangTrainer GT1, Lokomat and Conventional Physiotherapy Registry record

    Expected 2016-02; that period ended on 2016-02-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01146587

  85. Study completion The Effects of Pravastatin and Rosuvastatin on Coronary Plaques in Patients With Stable Angina Pectoris Registry record

    Expected 2016-02; that period ended on 2016-02-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01325818

  86. Study completion Comparison of the Quality of CPR by Lay Rescuers With and Without Feedback Devices Registry record

    Expected 2016-02; that period ended on 2016-02-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02000505

  87. Study completion A Study of tDCS for Unilateral Neglect in Stroke Patients Registry record

    Expected 2016-02; that period ended on 2016-02-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02506075

  88. Primary completion A Study of tDCS for Unilateral Neglect in Stroke Patients Registry record

    Expected 2016-02; that period ended on 2016-02-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02506075

  89. Study completion Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD Registry record

    Expected 2016-02; that period ended on 2016-02-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02551172

  90. Study completion HFS-guided Renal Ablation for Improving Outcome of Renal Denervation Procedure Registry record

    Expected 2016-02; that period ended on 2016-02-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02608632

  91. Primary completion Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2 Registry record

    Expected 2016-03; that period ended on 2016-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01561222

  92. Study completion Single Long vs Two Short Overlapping Bioabsorbable Polymer DES Registry record

    Expected 2016-03; that period ended on 2016-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01718106

  93. Study completion Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy Registry record

    Expected 2016-03; that period ended on 2016-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01823185

  94. Primary completion Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy Registry record

    Expected 2016-03; that period ended on 2016-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01893788

  95. Study completion Comparative Phase IV Study: Efficacy And Safety of TiTAN2 Versus COBALT-CHROME Stents- EVIDENCEII Registry record

    Expected 2016-03; that period ended on 2016-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01918150

  96. Primary completion Safety and Efficacy Study of LAmbre LAA Closure Device for Treating AF Patients Who Cannot Take Warfarin Registry record

    Expected 2016-03; that period ended on 2016-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02029014

  97. Primary completion Sham Controlled Study of Renal Denervation for Subjects With Uncontrolled Hypertension Registry record

    Expected 2016-03; that period ended on 2016-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02029885

  98. Study completion Effect of Paired Testing to Poorly Controlled Chinese Diabetes on Glycemic Control and Self Care Registry record

    Expected 2016-03; that period ended on 2016-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02225691

  99. Study completion Comparison of Primary PCI vs. Post-thrombolysis PCI as Reperfusion Strategies in STEMI Registry record

    Expected 2016-03; that period ended on 2016-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02268669

  100. Study completion The Mobile Diabetes Mgmt. Study With Type 2 Diabetes Registry record

    Expected 2016-03; that period ended on 2016-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02451631